Sramana Mitra: In a fifteen-year span, the early venture guys are trying to go to $100 million in revenue and commensurate valuation in five to seven years. So, if they want to cash out the fact that you’re staying private in 15 years, that means that there is going to be some amount of change
Sramana Mitra: That means architecturally, you’re going to put a recording and transcription agent on the iPad, this is not happening on the cloud, right? Daniel Cane: Right. There are several reasons for this approach. First and foremost, it’s about performance and latency. By keeping everything on the device, we’re minimizing the amount of information
Sramana Mitra: Double click down for me on the AI aspect. I know you were doing AI right up front, but of course, AI has evolved. The market has evolved. Market’s receptivity to AI has evolved. AI has come of age, so to speak in the last fifteen years. Where are you with AI? What
Sramana Mitra: I purposely actually picked to highlight the positioning points where you can differentiate it versus areas where you cannot really differentiate. The domain of billing is less of a big differentiation in ModMed. The bigger differentiation is in the specialty specific content, specialty specific workflow and specialty specific treatment, right?
Sramana Mitra: Okay. So that’s one positioning differentiation. What about within the private practice market? Why do your customers pick you and what is special about it? What are the needs of a dermatology private practice or an OB-GYN practice or a plastic surgery practice? What’s special about each of these individual types of practices?
I first spoke with Dan a decade back. Here is the story. This conversation offers insights on his scaling strategy with ModMed.